Skip to content

Creditors' voluntary liquidation SOLATUMFARMA LTD

Northampton10055689-cvlOrder dated 21/05/2020Updated 04/10/2026, 05:40
More details available to registered users
Free access to practitioner details, reports and alerts

SOLATUMFARMA LTD in Northampton (East Midlands) entered creditors' voluntary liquidation. Ninos Koumettou has been appointed as insolvency practitioner. The case reference is 10055689-cvl. The principal activity of SOLATUMFARMA LTD is wholesale of pharmaceutical goods. 7 reports are available.

General information

NameSOLATUMFARMA LTD
TownNorthampton (East Midlands)
Company number10055689
Case no.10055689-cvl
StatusCreditors' voluntary liquidation
Order date21/05/2020
Company typePrivate limited company
Incorporated on10/03/2016
Company statusdissolved
Dissolved on06/09/2025

Sector

GroupWholesale and retail trade
Primary codeWholesale of pharmaceutical goods (46460)

Offices and addresses

Registered office
Suite 501 Unit 2 94a Wycliffe Road
NN1 5JF Northampton

Directors

Directors are visible after free registrationRegister free

Notices

21/05/2020Resolution
3566139
21/05/2020CompanyIssuedLiquidatorAppointment
3566138

Insolvency practitioner

Ninos Koumettou
Address1 Kings Avenue Winchmore Hill, N21 3NA London
Yiannis Koumettou
Address1 Kings Avenue Winchmore Hill, N21 3NA London
Practitioner contact details are visible after free registrationRegister free

InsolvencyIndex draws on public sources and makes every effort to keep the content of this page up to date and complete. Despite that care, the content may be incomplete or inaccurate. InsolvencyIndex provides the content of this website "as is", without any warranty as to its soundness, fitness for a particular purpose or otherwise. InsolvencyIndex accepts no liability for loss arising from, or in any way connected with, the use of this website or any inability to consult it. Save as set out in this disclaimer, InsolvencyIndex is not responsible for third-party files linked from this page; linking does not imply any endorsement of those files. Notices reproduced here are extracts from official publications; if you believe an entry is inaccurate, please contact us and we will correct it.